KPMG

Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b
Podcast

Biopharma's rebound keeping pace so far

This week on "The Top Line," we explore biopharma's rebound, dealmaking momentum and what's cutting through the noise in 2026.
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Consumers remain averse to out-of-pocket GLP-1 costs: KPMG

May 15, 2025 12:01am
The Top Line

Navigating Trump’s tariffs for pharma

Apr 18, 2025 9:35am
President Donald Trump outlines new tariffs during an executive order signing event at the White House

Trump's 'Liberation Day' tariffs seem to spare drugs—for now

Apr 2, 2025 7:32pm
CEO generic CEO

Most biopharma CEOs expect growth over next 3 years: survey

Nov 27, 2024 8:25am
Lawyers reviewing paperwork

With arsenal of firepower, EY sees uptick in pharma M&A in 2024

Jan 8, 2024 8:04am